DOI: 10.1055/s-00000077

Seminars in Thrombosis and Hemostasis

Issue 05 · Volume 36 · July 2010 DOI: 10.1055/s-002-21194 Recombinants in Thrombosis and Hemostasis: From Basic Research to Clinical Therapy Giuseppe Lippi M.D. Emmanuel J Favaloro Ph.D. M.A.I.M.S.

EDITORIAL

  • 469
    Favaloro, Emmanuel J:

    2009 Eberhard F. Mammen Young Investigator Award Winners

    • PREFACE

  • 471
    Lippi, Giuseppe; Favaloro, Emmanuel J:

    Recombinants in Thrombosis and Hemostasis: From Basic Research to Clinical Therapy

  • 477
    Bowman, Lyndsey J; Anderson, Christopher D; Chapman, William C:

    Topical Recombinant Human Thrombin in Surgical Hemostasis

  • 485
    Franchini, Massimo; Lippi, Giuseppe:

    Recombinant Activated Factor VII: Mechanisms of Action and Current Indications

  • 493
    Franchini, Massimo; Lippi, Giuseppe:

    Recombinant Factor VIII Concentrates

  • 498
    Monahan, Paul E; Di Paola, Jorge:

    Recombinant Factor IX for Clinical and Research Use

  • 510
    Turecek, Peter L; Schrenk, Gerald; Rottensteiner, Hanspeter; Varadi, Katalin; Bevers, Edouard; Lenting, Peter; Ilk, Nicola; Sleytr, Uwe B; Ehrlich, Hartmut J; Schwarz, Hans Peter:

    Structure and Function of a Recombinant von Willebrand Factor Drug Candidate

  • 522
    Muchitsch, Eva-Maria; Dietrich, Barbara; Rottensteiner, Hanspeter; Auer, Wilfried; Nehrbass, Dirk; Gritsch, Herbert; Ehrlich, Hartmut J; Turecek, Peter L; Peter Schwarz, Hans:

    Preclinical Testing of Human Recombinant von Willebrand Factor: ADAMTS13 Cleavage Capacity in Animals as Criterion for Species Suitability

  • 529
    Campbell, Jennifer; Hilleman, Daniel:

    Recombinant Peptides in Thrombolysis

  • 537
    Lippi, Giuseppe; Franchini, Massimo; Favaloro, Emmanuel J:

    Thrombotic Complications of Erythropoiesis-Stimulating Agents

  • 550
    Levi, Marcel; Lowenberg, Ester; Meijers, Joost C:

    Recombinant Anticoagulant Factors for Adjunctive Treatment of Sepsis

  • 558
    Lippi, Giuseppe; Favaloro, Emmanuel J:

    Recombinant Platelet Factor 4: A Therapeutic, Anti-Neoplastic Chimera?